Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to con...
Հիմնական հեղինակներ: | Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
American Society for Microbiology
2017
|
Նմանատիպ նյութեր
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
: Chotsiri, P, և այլն
Հրապարակվել է: (2019) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
: Palang Chotsiri, և այլն
Հրապարակվել է: (2019-01-01) -
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
: Bergstrand, M, և այլն
Հրապարակվել է: (2014) -
Efficacy and safety of dihydroartemisinin-piperaquine.
: Myint, H, և այլն
Հրապարակվել է: (2007) -
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
: Lwin, K, և այլն
Հրապարակվել է: (2012)